Late complications after radiotherapy for prostate cancer

被引:4
|
作者
Jung, H. [1 ,2 ]
Beck-Bornholdt, H. -P. [2 ]
Svoboda, V. [2 ,4 ]
Alberti, W.
Herrmann, T. [3 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Lab Radiobiol & Expt Radiooncol, D-20246 Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Inst Biophys & Radiobiol, D-20246 Hamburg, Germany
[3] Tech Univ Dresden, Dept Radiotherapy & Radiooncol, Dresden, Germany
[4] St Marys Hosp, Dept Radiotherapy, Dept Clin Oncol, Portsmouth Oncol Ctr, Portsmouth PO3 6AQ, Hants, England
关键词
Late effects; Complications; Radiotherapy; Prostate cancer; Kinetics of late effects; LATE RECTAL TOXICITY; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY;
D O I
10.1007/s00066-012-0142-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects. A total of 180 consecutive patients received radiotherapy for prostate cancer. The median age was 66 years (range 41-88 years). The median of the maximum dose was 77.5 Gy (range 56.3-95 Gy) and overall treatment time was 51 days (range 28-128 days). Endpoints analyzed were late complications of grade 3 or higher, overall and disease-free survival, local tumor control, and distant metastases. Data analysis was actuarial and the log-rank test was used to compare the various subgroups. After 2 years, 80.5 +/- 3.2% of the patients were without any complications of grade 3 or higher, and after 5 years a constant level of 70.3 +/- 4.0% was approached. When multiple lesions occurred per patient, the later events were disregarded. A total of 66 complications occurred in 42 patients. The percentage of patients being free from late complications, plotted as a function of time after start of radiation therapy, was adequately described by an exponential function and a constant fraction. Complications approached a constant level of 70.3% at a rate of 5.3% per month. This means that patients who will develop a complication do so at exponential kinetics and at a relatively high rate, whereas about 70% of the patients will never experience a late effect even over long observation periods. After subdividing the maximum dose into three equal dose groups of 55 patients each (< 73.3 Gy, 73.3-80 Gy, > 80 Gy), the constant fraction decreased from 85.7 to 72.8% and 52.2%, whereas the incidence rate was 4.3%, 7.7%, and 5.6% per month and, thus, almost independent of radiation dose. For a given group of patients, the rate of the incidence of late complications appears to be independent of radiation dose and (from analyzing data in the literature) independent of the grade of lesions, whereas the fraction of patients without late effects depends on both parameters.
引用
收藏
页码:965 / 974
页数:10
相关论文
共 50 条
  • [1] Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer
    Kozuka, Takuyo
    Nakano, Masahiro
    Hashimoto, Masatoshi
    Gomi, Kotaro
    Murofushi, Keiko Nemoto
    Sumi, Minako
    Yonese, Junji
    Oguchi, Masahiko
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (05) : 269 - 278
  • [2] Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer
    Takuyo Kozuka
    Masahiro Nakano
    Masatoshi Hashimoto
    Kotaro Gomi
    Keiko Nemoto Murofushi
    Minako Sumi
    Junji Yonese
    Masahiko Oguchi
    [J]. Japanese Journal of Radiology, 2017, 35 : 269 - 278
  • [3] Complications of the radiotherapy of prostate cancer
    Richaud, Pierre
    Moreau, Jean-Luc
    Eschwege, Pascal
    [J]. PROGRES EN UROLOGIE, 2006, 16 (06): : 733 - 734
  • [4] THE SCOPE AND MANAGEMENT OF URETHRAL COMPLICATIONS AFTER RADIOTHERAPY FOR PROSTATE CANCER
    Witten, Jon
    Rourke, Keith
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E573 - E574
  • [5] ACUTE SIDE-EFFECTS AND LATE COMPLICATIONS AFTER RADIOTHERAPY OF LOCALIZED CARCINOMA OF THE PROSTATE
    DEWIT, L
    ANG, KK
    VANDERSCHUEREN, E
    [J]. CANCER TREATMENT REVIEWS, 1983, 10 (02) : 79 - &
  • [6] Late side effects after conformal radiotherapy of patients with prostate cancer
    Geinitz, H.
    Zimmermann, F.
    Thamm, R.
    Mueller, T.
    Jess, K.
    Erber, C.
    Busch, R.
    Molls, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 75 - 75
  • [7] Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
    Romain Mathieu
    Juan David Ospina Arango
    Véronique Beckendorf
    Jean-Bernard Delobel
    Taha Messai
    Ciprian Chira
    Alberto Bossi
    Elisabeth Le Prisé
    Stéphane Guerif
    Jean-Marc Simon
    Bernard Dubray
    Jian Zhu
    Jean-Léon Lagrange
    Pascal Pommier
    Khemara Gnep
    Oscar Acosta
    Renaud De Crevoisier
    [J]. World Journal of Urology, 2014, 32 : 743 - 751
  • [8] Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
    Mathieu, Romain
    Ospina Arango, Juan David
    Beckendorf, Veronique
    Delobel, Jean-Bernard
    Messai, Taha
    Chira, Ciprian
    Bossi, Alberto
    Prise, Elisabeth Le
    Guerif, Stephane
    Simon, Jean-Marc
    Dubray, Bernard
    Zhu, Jian
    Lagrange, Jean-Leon
    Pommier, Pascal
    Gnep, Khemara
    Acosta, Oscar
    De Crevoisier, Renaud
    [J]. WORLD JOURNAL OF UROLOGY, 2014, 32 (03) : 743 - 751
  • [9] Acute- and late toxicity after percutaneous radiotherapy of prostate cancer
    Brinkmann, R.
    Niewald, M.
    Fleckenstein, V.
    Wullich, B.
    Ruebe, C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 117 - 117
  • [10] Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
    Mathieu, Romain
    Arango, Juan David Ospina
    Beckendorf, Veronique
    Delobel, Jean Bernard
    Messai, Taha
    Bossi, Alberto
    Le Prise, Elisabeth
    Guerif, Stephane
    Simon, Jean-Marc
    Dubray, Bernard M.
    Zhu, Jian
    Lagrange, Jean-Leon
    Pommier, Pascal
    Gnep, Khemara
    Acosta, Oscar
    de Crevoisier, Renaud
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)